|
End-of-day quote
Santiago S.E.
|
||
| - CLP | - |
|
| 17/05/14 | Abbott Laboratories : to buy Latin American drugmaker CFR in $2.9 billion deal | RE |
| 16/05/14 | AbbVie : Abbott to buy Latin American drugmaker CFR in $2.9 billion deal | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| +6.63% | +5.13% | +15.96% | +13.53% | +27.82% | +68.86% | +145.20% | +439.21% | +1,743.15% | 1,224B | |
| +1.53% | +2.84% | +2.85% | +3.64% | +32.98% | +47.48% | +89.01% | +68.96% | +138.62% | 662B | |
| +1.68% | +1.96% | +10.44% | +10.44% | +27.27% | +29.16% | +109.31% | +153.59% | +404.84% | 514B | |
| +0.73% | +2.45% | +15.00% | +11.06% | +22.39% | +54.26% | +68.96% | +13.46% | +74.80% | 388B | |
| +3.83% | -0.62% | -1.98% | +12.25% | +39.02% | +69.01% | +42.32% | +66.19% | +148.69% | 361B | |
| +2.38% | +2.65% | +9.41% | +1.97% | +20.71% | +34.31% | +57.95% | +74.91% | +86.08% | 302B | |
| +2.26% | +0.55% | +5.02% | -0.62% | -5.35% | +3.92% | +28.92% | +43.52% | +182.69% | 271B | |
| +1.97% | +3.01% | +8.76% | +18.86% | +40.76% | +57.91% | +76.14% | +122.61% | +217.35% | 249B | |
| +4.03% | +5.36% | +9.47% | +24.77% | +34.93% | +39.76% | +116.14% | +155.26% | +124.16% | 205B | |
| +2.10% | -1.66% | +3.46% | -22.98% | -19.95% | -22.25% | -60.56% | -26.07% | +119.24% | 172B | |
| +1.70% | -1.55% | +4.28% | +19.09% | +20.28% | +23.30% | -0.53% | -31.53% | -6.20% | 171B | |
| +1.95% | +0.90% | +2.52% | +11.72% | +19.11% | +29.43% | +51.99% | +192.00% | +596.06% | 137B | |
| +1.35% | -2.56% | -2.34% | -2.71% | +13.81% | +44.11% | +20.33% | +5.12% | +20.37% | 125B | |
| +2.12% | -3.11% | +13.42% | +10.39% | +19.58% | +21.45% | +118.93% | +371.85% | +690.33% | 114B | |
| +0.85% | +1.60% | +6.55% | -4.72% | -7.94% | -13.39% | -6.50% | -11.89% | +6.61% | 102B | |
| -0.96% | -5.22% | -2.26% | -9.62% | -0.58% | +3.54% | +26.57% | -3.80% | -10.83% | 97.25B | |
| +4.01% | +9.93% | +9.49% | +308.81% | +655.37% | +801.86% | +209.78% | -35.47% | - | 88.93B | |
| +0.68% | -0.04% | +9.10% | +17.74% | +6.08% | +25.40% | +5.62% | +27.94% | +130.10% | 81.76B | |
| +2.91% | +2.70% | +9.39% | +3.58% | +22.59% | +30.75% | +5.10% | -26.40% | +59.47% | 72.96B | |
| Average | +1.96% | +1.28% | +6.77% | +22.48% | +50.99% | +70.99% | +58.14% | +84.18% | +262.53% | 266.95B | |
| Weighted average by Cap. | +2.11% | +2.31% | +8.59% | +13.63% | +33.90% | +55.72% | +81.89% | +157.94% | +546.25% |
- Stock Market
- Stocks
- CFR Stock
- Sector CFR Pharmaceuticals SA
Select your edition
All financial news and data tailored to specific country editions
